Storia della carriera di Nicholas Vlahakis
Precedenti posizioni note di Nicholas Vlahakis
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| COHBAR, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2022 | 01/05/2023 |
| UNITY BIOTECHNOLOGY, INC. | Corporate Officer/Principal | - | - |
| GLOBAL BLOOD THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Formazione di Nicholas Vlahakis
| University of Adelaide | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Australia | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| COHBAR, INC. | Health Technology |
| UNITY BIOTECHNOLOGY, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Nicholas Vlahakis
- Esperienza
